Endocan as a Marker of Endotheliitis in Covid-19 Patients: Modulation by Veno-Venous Extracorporeal Membrane Oxygenation, Arterial Hypertension and Previous Treatment with Renin-Angiotensin-Aldosterone System Inhibitors
AuthID
P-017-YSZ
P-017-YSZ